{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:18:31Z","timestamp":1793506711584,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Gastric cancer remains a major health concern worldwide, with locally advanced gastric cancer (LAGC) posing significant challenges due to frequent lymph node metastasis and poor prognosis. While curative gastrectomy with D2 lymph node dissection is the standard treatment, sarcopenia and perioperative skeletal muscle loss (SML) have emerged as critical prognostic factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We retrospectively analyzed 198 LAGC patients who underwent curative gastrectomy. Preoperative and postoperative sarcopenia were assessed via computed tomography (CT)-derived skeletal muscle index (SMI) at the L3 level. SML was defined based on sex-specific thresholds of SMI changes (%\/30 days). Prognostic significance for overall survival (OS) and disease-free survival (DFS) was evaluated using Kaplan-Meier and Cox regression analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The prevalence of sarcopenia increased from 23.7% preoperatively to 33.3% postoperatively. Patients with significant muscle loss (SML) showed worse OS and DFS compared to non-SML patients (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). SML was also associated with a higher incidence of Clavien-Dindo grade\u2009\u2265\u20093a complications (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Multivariate analysis identified preoperative sarcopenia (HR\u2009=\u20092.332, <jats:italic>P<\/jats:italic>\u2009=\u20090.001), postoperative sarcopenia (HR\u2009=\u20093.189, <jats:italic>P<\/jats:italic>\u2009=\u20090.011), and SML (HR\u2009=\u200911.231, <jats:italic>P<\/jats:italic>\u2009=\u20090.002) as independent risk factors for OS. Adjuvant chemotherapy significantly improved both OS (HR\u2009=\u20090.532, <jats:italic>P<\/jats:italic>\u2009=\u20090.015) and DFS (HR\u2009=\u20090.587, <jats:italic>P<\/jats:italic>\u2009=\u20090.041).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Both preoperative sarcopenia and perioperative SML may negatively impact postoperative prognosis in LAGC patients, suggesting that perioperative evaluation of skeletal muscle mass may help identify high-risk surgical candidates for targeted interventions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-13674-3","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:35:26Z","timestamp":1739558126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Preoperative sarcopenia and postoperative accelerated muscle loss negatively impact survival after resection of locally advanced gastric cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaolong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping\u2019an","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peigang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"13674_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Giaquinto AN, Jemal A, Cancer statistics, Cancer JC. 2024 Jan-Feb;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820. Epub 2024 Jan 17.","DOI":"10.3322\/caac.21820"},{"issue":"5","key":"13674_CR2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold M, Park JY, Camargo MC, Lunet N, Forman D, Soerjomataram I. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 2020;69(5):823\u20139. https:\/\/doi.org\/10.1136\/gutjnl-2019-320234.","journal-title":"Gut"},{"issue":"4","key":"13674_CR3","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","volume":"39","author":"RE Sexton","year":"2020","unstructured":"Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39(4):1179\u2013203. https:\/\/doi.org\/10.1007\/s10555-020-09925-3.","journal-title":"Cancer Metastasis Rev"},{"issue":"Pt 3","key":"13674_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.semcancer.2021.12.004","volume":"86","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Jin RU. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer. Semin Cancer Biol. 2022;86(Pt 3):566\u201382. https:\/\/doi.org\/10.1016\/j.semcancer.2021.12.004.","journal-title":"Semin Cancer Biol"},{"issue":"23","key":"13674_CR5","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.2217\/fon-2017-0282","volume":"13","author":"SG Barreto","year":"2017","unstructured":"Barreto SG, Sirohi B. Why should we perform a D2 lymphadenectomy in gastric cancer? Future Oncol. 2017;13(23):2009\u201312. https:\/\/doi.org\/10.2217\/fon-2017-0282.","journal-title":"Future Oncol"},{"issue":"1","key":"13674_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.suc.2024.06.005","volume":"105","author":"J Hwang","year":"2025","unstructured":"Hwang J, Carr J. Lymphadenectomy for gastric Cancer. Surg Clin North Am. 2025;105(1):47\u201354. https:\/\/doi.org\/10.1016\/j.suc.2024.06.005.","journal-title":"Surg Clin North Am"},{"key":"13674_CR7","doi-asserted-by":"publisher","first-page":"1037200","DOI":"10.3389\/fnut.2023.1037200","volume":"10","author":"J Wu","year":"2023","unstructured":"Wu J, Ding P, Wu H, Yang P, Guo H, Tian Y, Meng L, Zhao Q. Sarcopenia: molecular regulatory network for loss of muscle mass and function. Front Nutr. 2023;10:1037200. https:\/\/doi.org\/10.3389\/fnut.2023.1037200.","journal-title":"Front Nutr"},{"key":"13674_CR8","doi-asserted-by":"publisher","first-page":"981533","DOI":"10.3389\/fnut.2022.981533","volume":"9","author":"P Ding","year":"2022","unstructured":"Ding P, Lv J, Sun C, Chen S, Yang P, Tian Y, Zhou Q, Guo H, Liu Y, Zhao Q. Combined systemic inflammatory immunity index and prognostic nutritional index scores as a screening marker for Sarcopenia in patients with locally advanced gastric cancer. Front Nutr. 2022;9:981533. https:\/\/doi.org\/10.3389\/fnut.2022.981533.","journal-title":"Front Nutr"},{"key":"13674_CR9","doi-asserted-by":"publisher","first-page":"112408","DOI":"10.1016\/j.nut.2024.112408","volume":"123","author":"P Ding","year":"2024","unstructured":"Ding P, Wu H, Li T, Wu J, Yang L, Yang J, Guo H, Tian Y, Yang P, Meng L, Zhao Q. Impact of preoperative sarcopenia on postoperative complications and prognosis in patients undergoing robotic gastric cancer surgery: a propensity score matching study. Nutrition. 2024;123:112408. https:\/\/doi.org\/10.1016\/j.nut.2024.112408.","journal-title":"Nutrition"},{"issue":"8","key":"13674_CR10","doi-asserted-by":"publisher","first-page":"e14201","DOI":"10.1111\/eci.14201","volume":"54","author":"P Ding","year":"2024","unstructured":"Ding P, Wu J, Wu H, Li T, Yang J, Yang L, Guo H, Tian Y, Yang P, Meng L, Zhao Q. Myosteatosis predicts postoperative complications and long-term survival in robotic gastrectomy for gastric cancer: a propensity score analysis. Eur J Clin Invest. 2024;54(8):e14201. https:\/\/doi.org\/10.1111\/eci.14201.","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"13674_CR11","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1111\/jgh.16681","volume":"39","author":"WL Lin","year":"2024","unstructured":"Lin WL, Nguyen TH, Huang WT, Guo HR, Wu LM. Sarcopenia and survival in colorectal cancer without distant metastasis: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2024;39(11):2250\u20139. https:\/\/doi.org\/10.1111\/jgh.16681.","journal-title":"J Gastroenterol Hepatol"},{"key":"13674_CR12","doi-asserted-by":"publisher","first-page":"1247341","DOI":"10.3389\/fonc.2023.1247341","volume":"13","author":"J He","year":"2023","unstructured":"He J, Luo W, Huang Y, Song L, Mei Y. Sarcopenia as a prognostic indicator in colorectal cancer: an updated meta-analysis. Front Oncol. 2023;13:1247341. https:\/\/doi.org\/10.3389\/fonc.2023.1247341.","journal-title":"Front Oncol"},{"issue":"1","key":"13674_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12957-024-03310-y","volume":"22","author":"C Liu","year":"2024","unstructured":"Liu C, An L, Zhang S, Deng S, Wang N, Tang H. Association between preoperative Sarcopenia and prognosis of pancreatic cancer after curative-intent surgery: a updated systematic review and meta-analysis. World J Surg Oncol. 2024;22(1):38. https:\/\/doi.org\/10.1186\/s12957-024-03310-y.","journal-title":"World J Surg Oncol"},{"issue":"8","key":"13674_CR14","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.acra.2022.10.025","volume":"30","author":"M Thormann","year":"2023","unstructured":"Thormann M, Hinnerichs M, Barajas Ordonez F, Saalfeld S, Perrakis A, Croner R, Omari J, Pech M, Zamsheva M, Meyer HJ, Wienke A, Surov A. Sarcopenia is an independent prognostic factor in patients with pancreatic Cancer - a Meta-analysis. Acad Radiol. 2023;30(8):1552\u201361. https:\/\/doi.org\/10.1016\/j.acra.2022.10.025.","journal-title":"Acad Radiol"},{"issue":"6","key":"13674_CR15","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1002\/jcsm.13068","volume":"13","author":"J Lortie","year":"2022","unstructured":"Lortie J, Gage G, Rush B, Heymsfield SB, Szczykutowicz TP, Kuchnia AJ. The effect of computed tomography parameters on Sarcopenia and myosteatosis assessment: a scoping review. J Cachexia Sarcopenia Muscle. 2022;13(6):2807\u201319. https:\/\/doi.org\/10.1002\/jcsm.13068.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10","key":"13674_CR16","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/gerona\/glz034","volume":"74","author":"B Amini","year":"2019","unstructured":"Amini B, Boyle SP, Boutin RD, Lenchik L. Approaches to Assessment of muscle Mass and myosteatosis on computed tomography: a systematic review. J Gerontol Biol Sci Med Sci. 2019;74(10):1671\u20138. https:\/\/doi.org\/10.1093\/gerona\/glz034.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"6","key":"13674_CR17","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1016\/j.clnu.2021.04.017","volume":"40","author":"HK Kim","year":"2021","unstructured":"Kim HK, Kim KW, Kim EH, Lee MJ, Bae SJ, Ko Y, Park T, Shin Y, Kim YJ, Choe J. Age-related changes in muscle quality and development of diagnostic cutoff points for myosteatosis in lumbar skeletal muscles measured by CT scan. Clin Nutr. 2021;40(6):4022\u20138. https:\/\/doi.org\/10.1016\/j.clnu.2021.04.017.","journal-title":"Clin Nutr"},{"issue":"suppl2","key":"13674_CR18","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1093\/annonc\/mdx810","volume":"29","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Arribas L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol. 2018;29(suppl2):ii1\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdx810.","journal-title":"Ann Oncol"},{"issue":"2","key":"13674_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/jcsm.12165","volume":"8","author":"O Klassen","year":"2017","unstructured":"Klassen O, Schmidt ME, Ulrich CM, Schneeweiss A, Potthoff K, Steindorf K, Wiskemann J. Muscle strength in breast cancer patients receiving different treatment regimes. J Cachexia Sarcopenia Muscle. 2017;8(2):305\u201316. https:\/\/doi.org\/10.1002\/jcsm.12165. Epub 2016 Nov 28.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"13674_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1002\/jcsm.13462","volume":"15","author":"JY Jang","year":"2024","unstructured":"Jang JY, Oh D, Noh JM, Sun JM, Kim HK, Shim YM. Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy. J Cachexia Sarcopenia Muscle. 2024;15(3):1167\u201376. https:\/\/doi.org\/10.1002\/jcsm.13462.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"13674_CR21","doi-asserted-by":"publisher","first-page":"e0220660","DOI":"10.1371\/journal.pone.0220660","volume":"14","author":"JG Lee","year":"2019","unstructured":"Lee JG, Kim SA, Eun CS, Han DS, Kim YS, Choi BY, Song KS, Kim HJ, Park CH. Impact of age on stage-specific mortality in patients with gastric cancer: a long-term prospective cohort study. PLoS ONE. 2019;14(8):e0220660. https:\/\/doi.org\/10.1371\/journal.pone.0220660.","journal-title":"PLoS ONE"},{"issue":"7","key":"13674_CR22","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.7150\/jca.22085","volume":"9","author":"J Zhang","year":"2018","unstructured":"Zhang J, Gan L, Xu MD, Huang M, Zhang X, Gong Y, Wang X, Yu G, Guo W. The prognostic value of age in non-metastatic gastric cancer after gastrectomy: a retrospective study in the U.S. and China. J Cancer. 2018;9(7):1188\u201399. https:\/\/doi.org\/10.7150\/jca.22085.","journal-title":"J Cancer"},{"issue":"1","key":"13674_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","volume":"85","author":"N Mitsiopoulos","year":"1998","unstructured":"Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985). 1998;85(1):115\u201322. https:\/\/doi.org\/10.1152\/jappl.1998.85.1.115.","journal-title":"J Appl Physiol (1985)"},{"issue":"8","key":"13674_CR24","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/annonc\/mdu086","volume":"25","author":"D Blum","year":"2014","unstructured":"Blum D, Stene GB, Solheim TS, Fayers P, Hjermstad MJ, Baracos VE, Fearon K, Strasser F, Kaasa S, Euro-Impact. Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model\u2013a study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol. 2014;25(8):1635\u201342. https:\/\/doi.org\/10.1093\/annonc\/mdu086.","journal-title":"Ann Oncol"},{"issue":"2","key":"13674_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","volume":"15","author":"LK Chen","year":"2014","unstructured":"Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee WJ, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CW, Wu CH, Wu SN, Zhang T, Zeng P, Akishita M, Arai H. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95\u2013101. https:\/\/doi.org\/10.1016\/j.jamda.2013.11.025.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"13674_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12885-020-6645-6","volume":"20","author":"XM Zhang","year":"2020","unstructured":"Zhang XM, Dou QL, Zeng Y, Yang Y, Cheng ASK, Zhang WW. Sarcopenia as a predictor of mortality in women with breast cancer: a meta-analysis and systematic review. BMC Cancer. 2020;20(1):172. https:\/\/doi.org\/10.1186\/s12885-020-6645-6.","journal-title":"BMC Cancer"},{"issue":"2","key":"13674_CR27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jcsm.12524","volume":"11","author":"CY Huang","year":"2020","unstructured":"Huang CY, Yang YC, Chen TC, Chen JR, Chen YJ, Wu MH, Jan YT, Chang CL, Lee J. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer. J Cachexia Sarcopenia Muscle. 2020;11(2):534\u201346. https:\/\/doi.org\/10.1002\/jcsm.12524.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"13674_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nut.2017.09.005","volume":"47","author":"N Tewari","year":"2018","unstructured":"Tewari N, Awad S, Macdonald IA, Lobo DN. A comparison of three methods to assess body composition. Nutrition. 2018;47:1\u20135. https:\/\/doi.org\/10.1016\/j.nut.2017.09.005.","journal-title":"Nutrition"},{"issue":"3","key":"13674_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5230\/jgc.2018.18.e25","volume":"18","author":"S O\u2019Brien","year":"2018","unstructured":"O\u2019Brien S, Twomey M, Moloney F, Kavanagh RG, Carey BW, Power D, Maher MM, O\u2019Connor OJ. \u00d3\u2019S\u00failleabh\u00e1in C. Sarcopenia and post-operative morbidity and mortality in patients with gastric Cancer. J Gastric Cancer. 2018;18(3):242\u201352. https:\/\/doi.org\/10.5230\/jgc.2018.18.e25.","journal-title":"J Gastric Cancer"},{"issue":"3","key":"13674_CR30","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/cts.12940","volume":"14","author":"X Sun","year":"2021","unstructured":"Sun X, Xu J, Chen X, Zhang W, Chen W, Zhu C, Sun J, Yang X, Wang X, Hu Y, Cai Y, Shen X. Sarcopenia in patients with normal body Mass Index is an independent predictor for postoperative complication and long-term survival in gastric Cancer. Clin Transl Sci. 2021;14(3):837\u201346. https:\/\/doi.org\/10.1111\/cts.12940.","journal-title":"Clin Transl Sci"},{"issue":"4","key":"13674_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000504283","volume":"75","author":"B Shi","year":"2019","unstructured":"Shi B, Liu S, Chen J, Liu J, Luo Y, Long L, Lan Q, Zhang Y. Sarcopenia is Associated with Perioperative outcomes in gastric Cancer patients undergoing gastrectomy. Ann Nutr Metab. 2019;75(4):213\u201322. https:\/\/doi.org\/10.1159\/000504283.","journal-title":"Ann Nutr Metab"},{"issue":"6","key":"13674_CR32","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ejso.2018.09.030","volume":"45","author":"XY Chen","year":"2019","unstructured":"Chen XY, Li B, Ma BW, Zhang XZ, Chen WZ, Lu LS, Shen X, Zhuang CL, Yu Z. Sarcopenia is an effective prognostic indicator of postoperative outcomes in laparoscopic-assisted gastrectomy. Eur J Surg Oncol. 2019;45(6):1092\u20138. https:\/\/doi.org\/10.1016\/j.ejso.2018.09.030.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"13674_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/17474124.2021.1836959","volume":"15","author":"Z Fang","year":"2021","unstructured":"Fang Z, Du F, Shang L, Liu J, Ren F, Liu Y, Wu H, Liu Y, Li P, Li L. CT assessment of preoperative nutritional status in gastric cancer: severe low skeletal muscle mass and obesity-related low skeletal muscle mass are unfavorable factors of postoperative complications. Expert Rev Gastroenterol Hepatol. 2021;15(3):317\u201324. https:\/\/doi.org\/10.1080\/17474124.2021.1836959.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"13674_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/jso.24015","volume":"112","author":"JJ Tegels","year":"2015","unstructured":"Tegels JJ, van Vugt JL, Reisinger KW, Hulsew\u00e9 KW, Hoofwijk AG, Derikx JP, Stoot JH. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol. 2015;112(4):403\u20137. https:\/\/doi.org\/10.1002\/jso.24015.","journal-title":"J Surg Oncol"},{"issue":"3","key":"13674_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.clnu.2015.03.001","volume":"34","author":"T Cederholm","year":"2015","unstructured":"Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S, Muscaritoli M, Nyulasi I, Ockenga J, Schneider SM, de van der Schueren MA, Singer P. Diagnostic criteria for malnutrition - an ESPEN Consensus Statement. Clin Nutr. 2015;34(3):335\u201340. https:\/\/doi.org\/10.1016\/j.clnu.2015.03.001.","journal-title":"Clin Nutr"},{"issue":"9","key":"13674_CR36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","volume":"14","author":"JA Batsis","year":"2018","unstructured":"Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513\u201337. https:\/\/doi.org\/10.1038\/s41574-018-0062-9.","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"13674_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrendo.2012.49","volume":"8","author":"BK Pedersen","year":"2012","unstructured":"Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8(8):457\u201365. https:\/\/doi.org\/10.1038\/nrendo.2012.49.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"13674_CR38","doi-asserted-by":"publisher","first-page":"E504","DOI":"10.1152\/ajpendo.00520.2010","volume":"301","author":"P Hojman","year":"2011","unstructured":"Hojman P, Dethlefsen C, Brandt C, Hansen J, Pedersen L, Pedersen BK. Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth. Am J Physiol Endocrinol Metab. 2011;301(3):E504\u201310. https:\/\/doi.org\/10.1152\/ajpendo.00520.2010.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"13674_CR39","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3892\/ol.2018.8747","volume":"16","author":"N Kugimiya","year":"2018","unstructured":"Kugimiya N, Harada E, Oka K, Kawamura D, Suehiro Y, Takemoto Y, Hamano K. Loss of skeletal muscle mass after curative gastrectomy is a poor prognostic factor. Oncol Lett. 2018;16(1):1341\u20137. https:\/\/doi.org\/10.3892\/ol.2018.8747.","journal-title":"Oncol Lett"},{"issue":"8","key":"13674_CR40","doi-asserted-by":"publisher","first-page":"e0256365","DOI":"10.1371\/journal.pone.0256365","volume":"16","author":"K Sakurai","year":"2021","unstructured":"Sakurai K, Kubo N, Tamamori Y, Aomatsu N, Nishii T, Tachimori A, Nishiguchi Y, Maeda K. Depletion of skeletal muscle mass adversely affects long-term outcomes for men undergoing gastrectomy for gastric cancer. PLoS ONE. 2021;16(8):e0256365. https:\/\/doi.org\/10.1371\/journal.pone.0256365.","journal-title":"PLoS ONE"},{"issue":"5","key":"13674_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.clnu.2014.03.007","volume":"33","author":"G Biolo","year":"2014","unstructured":"Biolo G, Cederholm T, Muscaritoli M. Muscle contractile and metabolic dysfunction is a common feature of Sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr. 2014;33(5):737\u201348. https:\/\/doi.org\/10.1016\/j.clnu.2014.03.007.","journal-title":"Clin Nutr"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13674-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13674-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13674-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:35:28Z","timestamp":1739558128000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13674-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13674"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13674-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This cohort study was conducted under the approval of the Medical Ethics Committee of the Fourth Hospital of Hebei Medical University (Approval No. 2024KY198) following the recommendations of the Declaration of Helsinki. As this was a retrospective study that did not involve the disclosure of patient privacy and posed minimal risk, the requirement for informed consent was waived by the ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}